Retractable Technologies (NYSE:RVP) Stock Price Down 0.5% – Here’s Why

by · The Markets Daily

Retractable Technologies, Inc. (NYSE:RVP – Get Free Report) shares were down 0.5% during mid-day trading on Friday . The company traded as low as $0.82 and last traded at $0.8231. Approximately 19,961 shares changed hands during trading, a decline of 74% from the average daily volume of 75,755 shares. The stock had previously closed at $0.8276.

Retractable Technologies Stock Down 0.5%

The company’s 50 day moving average is $0.87 and its 200 day moving average is $0.79. The company has a market cap of $24.64 million, a PE ratio of -1.52 and a beta of 1.13. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01.

Insider Transactions at Retractable Technologies

In other news, CEO Thomas J. Shaw bought 35,000 shares of the firm’s stock in a transaction on Tuesday, October 28th. The stock was acquired at an average cost of $0.92 per share, with a total value of $32,200.00. Following the transaction, the chief executive officer directly owned 15,802,891 shares in the company, valued at approximately $14,538,659.72. This trade represents a 0.22% increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders purchased a total of 177,397 shares of company stock valued at $159,127 over the last quarter. 57.10% of the stock is owned by corporate insiders.

Institutional Trading of Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Susquehanna International Group LLP raised its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP – Free Report) by 135.3% during the third quarter, according to its most recent filing with the SEC. The firm owned 54,546 shares of the company’s stock after purchasing an additional 31,362 shares during the period. Susquehanna International Group LLP owned 0.18% of Retractable Technologies worth $46,000 at the end of the most recent reporting period. 7.58% of the stock is owned by institutional investors.

Retractable Technologies Company Profile

(Get Free Report)

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.

See Also